This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kochetkova, M. Articles by Callen, D. F. Search for Related Content PubMed PubMed Citation Articles by Kochetkova, M. Articles by Callen, D. F.

CBFA2T3 (MTG16) Is a Putative Breast Tumor Suppressor Gene from the Breast Cancer Loss of Heterozygosity Region at 16q24.3¹

Department of Cytogenetics and Molecular Genetics, Women’s and Children’s Hospital, North Adelaide 5006, South Australia, Australia [M. K., O. L. D. M., A. J. B., J. M. M., J .A. P., A. E. G., H. E. S., N. J. O., G. R. S.]; Bionomics Ltd, Thebarton, South Australia, Australia [G. A. S., S. J. H., S. A. W., J. C., G. K., D. F. C.]; Department of Hematology/Genetic Pathology, Flinders Medical Centre, Flinders University, Bedford Park. South Australia, Australia [R. S.]; and Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands [A-M. C-J, C. C.]

Numerous cytogenetic and molecular studies of breast cancer have identified frequent loss of heterozygosity (LOH) of the long arm of human chromosome 16. On the basis of these data, the likely locations of breast cancer tumor suppressor genes are bands 16q22.1 and 16q24.3. We have mapped the CBFA2T3 (MTG16) gene, previously cloned as a fusion partner of the AML1 protein from a rare (16;21) leukemia translocation, to the 16q24.3 breast cancer LOH region. The expression of CBFA2T3 was significantly reduced in a number of breast cancer cell lines and in primary breast tumors, including early ductal carcinomas in situ, when compared with nontransformed breast epithelial cell lines and normal breast tissue. Reintroduction of CBFA2T3 into different breast tumor derived cell lines with decreased expression of this gene reduced colony growth on plastic and in soft agar. CBFA2T3 was shown to function as a transcriptional repressor when tethered to the GAL4 DNA-binding domain in a reporter gene assay and, therefore, has the potential to be a transcriptional repressor in normal breast epithelial cells. Taken together, these findings suggest that CBFA2T3 is a likely candidate for the breast cancer tumor suppressor gene that is the target for the frequent 16q24 LOH in breast neoplasms.

This article has been cited by other articles:

				R. Kumar, K. M. Cheney, R. McKirdy, P. M. Neilsen, R. B. Schulz, J. Lee, J. Cohen, G. W. Booker, and D. F. Callen CBFA2T3-ZNF652 Corepressor Complex Regulates Transcription of the E-box Gene HEB J. Biol. Chem., July 4, 2008; 283(27): 19026 - 19038. [Abstract] [Full Text] [PDF]

				A. C. Moore, J. M. Amann, C. S. Williams, E. Tahinci, T. E. Farmer, J. A. Martinez, G. Yang, K. S. Luce, E. Lee, and S. W. Hiebert Myeloid Translocation Gene Family Members Associate with T-Cell Factors (TCFs) and Influence TCF-Dependent Transcription Mol. Cell. Biol., February 1, 2008; 28(3): 977 - 987. [Abstract] [Full Text] [PDF]

				M. Katzenellenbogen, L. Mizrahi, O. Pappo, N. Klopstock, D. Olam, J. Jacob-Hirsch, N. Amariglio, G. Rechavi, E. Domany, E. Galun, et al. Molecular Mechanisms of Liver Carcinogenesis in the Mdr2-Knockout Mice Mol. Cancer Res., November 1, 2007; 5(11): 1159 - 1170. [Abstract] [Full Text] [PDF]

				S. Gratias, H. Rieder, R. Ullmann, L. Klein-Hitpass, S. Schneider, R. Boloni, M. Kappler, and D. R. Lohmann Allelic Loss in a Minimal Region on Chromosome 16q24 Is Associated with Vitreous Seeding of Retinoblastoma Cancer Res., January 1, 2007; 67(1): 408 - 416. [Abstract] [Full Text] [PDF]

				M. T. Engelmark, E. L. Ivansson, J. J. Magnusson, I. M. Gustavsson, A. H. Beskow, P. K.E. Magnusson, and U. B. Gyllensten Identification of susceptibility loci for cervical carcinoma by genome scan of affected sib-pairs Hum. Mol. Genet., November 15, 2006; 15(22): 3351 - 3360. [Abstract] [Full Text] [PDF]

				R. Kumar, J. Manning, H. E. Spendlove, G. Kremmidiotis, R. McKirdy, J. Lee, D. N. Millband, K. M. Cheney, M. R. Stampfer, P. P. Dwivedi, et al. ZNF652, A Novel Zinc Finger Protein, Interacts with the Putative Breast Tumor Suppressor CBFA2T3 to Repress Transcription Mol. Cancer Res., September 1, 2006; 4(9): 655 - 665. [Abstract] [Full Text] [PDF]

				B. Linggi and G. Carpenter ErbB-4 s80 Intracellular Domain Abrogates ETO2-dependent Transcriptional Repression J. Biol. Chem., September 1, 2006; 281(35): 25373 - 25380. [Abstract] [Full Text] [PDF]

				R. Kumar, P. M. Neilsen, J. Crawford, R. McKirdy, J. Lee, J. A. Powell, Z. Saif, J. M. Martin, M. Lombaerts, C. J. Cornelisse, et al. FBXO31 Is the Chromosome 16q24.3 Senescence Gene, a Candidate Breast Tumor Suppressor, and a Component of an SCF Complex Cancer Res., December 15, 2005; 65(24): 11304 - 11313. [Abstract] [Full Text] [PDF]

				S. Rampalli, L. Pavithra, A. Bhatt, T. K. Kundu, and S. Chattopadhyay Tumor Suppressor SMAR1 Mediates Cyclin D1 Repression by Recruitment of the SIN3/Histone Deacetylase 1 Complex Mol. Cell. Biol., October 1, 2005; 25(19): 8415 - 8429. [Abstract] [Full Text] [PDF]